MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection

Abstract

Methyl-CpG binding domain 2 (MBD2) leads to the silencing of methylated genes in cancer cells and was implicated in the activation of prometastatic genes in hepatocellular carcinoma (HCC). The present study aimed to investigate the expression status of MBD2 in HCC and the correlation with surgical outcomes. The correlation between clinical prognostic… (More)
DOI: 10.3892/mmr.2016.5404

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Liu2016MBD2AA, title={MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection}, author={Wei Liu and Na Li Wang and Min Lu and Xiao-juan Du and Bao-cai Xing}, booktitle={Molecular medicine reports}, year={2016} }